R
Raffaele Bruno
Researcher at University of Pavia
Publications - 322
Citations - 14690
Raffaele Bruno is an academic researcher from University of Pavia. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 52, co-authored 275 publications receiving 11262 citations. Previous affiliations of Raffaele Bruno include University of Modena and Reggio Emilia.
Papers
More filters
Journal ArticleDOI
Ultrastructural Evidence of Direct Viral Damage to the Olfactory Complex in Patients Testing Positive for SARS-CoV-2.
Journal ArticleDOI
The societal burden of chronic liver diseases: results from the COME study
Luciana Scalone,Stefano Fagiuoli,Roberta Ciampichini,I. Gardini,Raffaele Bruno,Luisa Pasulo,Maria Grazia Lucà,F. Fusco,L. Gaeta,Anna Del Prete,Giancarlo Cesana,Lorenzo G. Mantovani +11 more
TL;DR: HBV-infected patients generated higher direct costs, patients with other aetiologies generated the highest productivity loss and HCV- infected patients reported the worst HRQoL levels.
Journal ArticleDOI
Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia.
Teresa Rampino,Marilena Gregorini,Luciano Perotti,Fiorenza Ferrari,Eleonora Francesca Pattonieri,Maria Antonietta Grignano,Mauro Valente,Alberto Garrone,Tefik Islam,Carmelo Libetta,Vincenzo Sepe,Riccardo Albertini,Raffaele Bruno,Mirko Belliato +13 more
TL;DR: The limited sample size and observational study design preclude a sound statement about the potential effectiveness of HP in CO VID-19 patients, but the experience suggests a potential therapeutic role of adjuvant CytoSorb HP in the early course of COVID-19 pneumonia.
Posted Content
CovidDeep: SARS-CoV-2/COVID-19 Test Based on Wearable Medical Sensors and Efficient Neural Networks
Shayan Hassantabar,Novati Stefano,Vishweshwar Ghanakota,Alessandra Ferrari,Gregory N. Nicola,Raffaele Bruno,Ignazio R. Marino,Kenza Hamidouche,Niraj K. Jha +8 more
TL;DR: A framework called CovidDeep is proposed that combines efficient DNNs with commercially available WMSs for pervasive testing of the virus and the resultant disease and is embedded in a smartphone application, which has the added benefit of preserving patient privacy.
Journal ArticleDOI
Hepatotoxicity and antiretroviral therapy with protease inhibitors: A review
TL;DR: It is suggested that based on differences in drug-related hepatotoxicity, certain protease inhibitors may be preferred for the treatment of human immunodeficiency virus-hepatitis C virus coinfected patients.